Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary

Can J Cardiol. 2009 Apr;25(4):197-205. doi: 10.1016/s0828-282x(09)70061-3.
No abstract available

Publication types

  • Consensus Development Conference

MeSH terms

  • Contraindications
  • Evidence-Based Medicine
  • Graft Rejection / classification
  • Graft Rejection / therapy
  • Heart Failure / physiopathology
  • Heart Failure / therapy
  • Heart Transplantation* / immunology
  • Heart Transplantation* / physiology
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Muromonab-CD3 / therapeutic use
  • Oxygen Consumption
  • Patient Selection
  • Postoperative Complications / epidemiology
  • Postoperative Complications / immunology
  • Postoperative Complications / therapy
  • Reoperation
  • Ventricular Dysfunction, Right / physiopathology

Substances

  • Immunosuppressive Agents
  • Muromonab-CD3